Diseases, Conditions, Syndromes

FDA approves Rinvoq for treatment of atopic dermatitis

The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.

Health

Q and A: What is pharmacogenomics?

DEAR MAYO CLINIC: I've been hearing a lot about lab tests that can look at my genetics to see how I metabolize medications. How does this work and why is it important for me to know how my body metabolizes medicine?

Medications

Simple monitoring could reduce medicine misuse in care homes

New research from Swansea University suggests that a simple nurse- or carer-led medicines' monitoring system can help reduce medication-related illness for people living in residential care homes—and the process takes just ...

page 4 from 17